Bibliome.ai browser hg19
Search
About
Stats
FAQ
PAK5 c.399C>G ;(p.S133R)
Variant ID: 20-9561383-G-C
NM_177990.2(
PAK5
):c.399C>G;(p.S133R)
This variant was identified in 3 publications
View GRCh38 version.
Variant-Specific Resource Links:
gnomAD v2.1.1
Mutalizer Name Checker
Google
UCSC Genome Browser
ClinVar
dbSNP
Publications:
Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms.
Frontiers In Immunology
Liu, Zhichao Z; Lin, Guo G; Yan, Zeping Z; Li, Linduo L; Wu, Xingchen X; Shi, Jingrong J; He, Jianxing J; Zhao, Lei L; Liang, Hengrui H; Wang, Wei W
Publication Date: 2022
Variant appearance in text: PAK7: 399C>G
PubMed Link:
36238300
Variant Present in the following documents:
Table_1.xlsx, sheet 4
View BVdb publication page
EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers.
Bmc Pulmonary Medicine
Li, Zhenxiang Z; Zhou, Qing Q; Wang, Qi Q; Wang, Haiyong H; Yue, Weiming W
Publication Date: 2022-09-19
Variant appearance in text: PAK7: 399C>G
PubMed Link:
36123678
Variant Present in the following documents:
12890_2022_2161_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page
Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Frontiers In Immunology
Li, Na N; Wang, Jiahong J; Zhan, Xianquan X
Publication Date: 2021
Variant appearance in text: PAK7: 399C>G
PubMed Link:
34887858
Variant Present in the following documents:
Table_4.xlsx, sheet 1
View BVdb publication page